AC
BXC icon

Apogem Capital’s BlueLinx BXC Stock Holding History

Apogem Capital’s Portfolio BXC Stock Details BXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-71,871
Closed -$4.46M – 16
2022
Q3 		$4.46M Sell
71,871
-6,200
-8% -$447K 4.45% 3
2022
Q2 		$5.22M Buy
78,071
+17,600
+29% +$1.32M 4.72% 2
2022
Q1 		$4.35M Buy
60,471
+562
+0.9% +$46K 2.97% 4
2021
Q4 		$5.74M Sell
59,909
-12,620
-17% -$855K 3.76% 3
2021
Q3 		$3.55M Hold
72,529
– – 2.26% 6
2021
Q2 		$3.65M Buy
72,529
+29,323
+68% +$1.44M 2.33% 3
2021
Q1 		$1.69M Sell
43,206
-63,000
-59% -$2.45M 1.15% 17
2020
Q4 		$3.11M Buy
+106,206
New +$2.72M 2.07% 7

Other funds holding BXC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NC
Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Apogem Capital's BXC Position: Q4 2022 in Review

Apogem Capital sold out of BlueLinx (BXC) in Q4 2022, closing a stake of 71,871 shares — an estimated $4.46M sold.

Apogem Capital first reported a position in BXC in Q4 2020 and held it in 8 quarters. The position peaked at $5.74M in Q4 2021. 145 funds tracked by Wall St. Rank hold BXC as of Q4 2022.

  • Apogem Capital reported no remaining BlueLinx position as of Q4 2022 after selling out during the quarter.
  • Apogem Capital sold 71,871 BlueLinx shares in Q4 2022, an estimated $4.46M.
  • Apogem Capital first reported a position in BlueLinx in Q4 2020 and held it in 8 quarters.
  • Apogem Capital's BlueLinx position peaked at $5.74M in Q4 2021.
  • 145 funds tracked by Wall St. Rank held BlueLinx as of Q4 2022.

Based on Apogem Capital's 13F filing for Q4 2022, filed 13 Feb 2023.